Edition:
United States

Express Scripts Holding Co (ESRX.O)

ESRX.O on Nasdaq

75.88USD
30 Nov 2016
Change (% chg)

-- (--)
Prev Close
$75.88
Open
--
Day's High
--
Day's Low
--
Volume
17
Avg. Vol
3,783,370
52-wk High
$89.00
52-wk Low
$64.46

Select another date:

Fri, Oct 28 2016

BRIEF-Express Scripts announces receipt of letter from internal revenue service

* Says on October 28, 2016, announced receipt of a letter from internal revenue service

Express Scripts gets subpoenas over drug company, pharmacy ties

Oct 25 Pharmacy benefit manager Express Scripts Holding Co has received subpoenas requesting information about its relationship with pharmaceutical companies, charitable foundations and specialty pharmacies, the company said in a regulatory filing on Tuesday.

BRIEF-Express Scripts Q3 earnings per share $1.15

* Narrowed its 2016 earnings per diluted share guidance from a range of $4.45 to $4.55 to a range of $4.47 to $4.53

Horizon Pharma to pay Express Scripts $65 million to settle rebate litigation

Horizon Pharma Plc said it would pay pharmacy benefit manager Express Scripts Holding $65 million to settle litigation related to after-market rebates for three of its medicines.

Horizon Pharma to pay Express Scripts $65 mln to settle rebate litigation

Horizon Pharma Plc said it would pay pharmacy benefit manager Express Scripts Holding $65 million to settle litigation related to after-market rebates for three of its medicines.

Horizon Pharma to pay Express Scripts $65 mln to settle rebate litigation

Sept 29 Horizon Pharma Plc said it would pay pharmacy benefit manager Express Scripts Holding $65 million to settle litigation related to after-market rebates for three of its medicines.

BRIEF-Horizon Pharma says unit enters into settlement deal with Express Scripts - SEC filing

* On Sept 26, Horizon Pharma USA entered settlement agreement and mutual release with Express Scripts to settle litigation - SEC filing

Express Scripts tries to rein in pricey inflammatory drugs

NEW YORK, Sept 8 Express Scripts Holding , the largest manager of U.S. drug benefits, on Thursday launched a program aimed at tightening spending on drugs for pricey inflammatory conditions such as rheumatoid arthritis.

BRIEF-Express Scripts adds Lilly's Taltz psoriasis drug to its excluded medicines list

Aug 1 Express Scripts : * says adds Eli Lilly's new Taltz psoriasis drug to its list of excluded medications, making it ineligible for coverage.

BRIEF-Express Scripts Q2 earnings per share $1.13

* Year adjusted diluted eps guidance range; raises mid-point; provides 2016 third quarter guidance

Select another date: